• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2101060 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2021-06-25 Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG view
CYSB2400155 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-06-18 Hisun Biopharmaceutical Co Ltd view
JYSB2101202 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2021-12-22 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
CYSB2300080 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2023-04-11 Shanghai Henlius Biopharmaceutical Co Ltd view
JYSB2101039 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2021-06-02 Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG view
JYSB2101038 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2021-06-02 Abbvie Ltd;Vetter Pharma-Fertigung Gmbh & Co KG view
CYSB2400050 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-02-29 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2200048 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2022-02-16 Innovent Biologics (Suzhou) Co Ltd view
CXSS2400138 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) New Drug Application 2024-12-14 Zhejiang HUAHAI Biopharmaceuticals Co Ltd view
CYSB2200049 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2022-02-16 Innovent Biologics (Suzhou) Co Ltd view
CYSB2200090 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2022-03-21 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group;Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
CYSB2400023 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-01-23 Hisun Biopharmaceutical Co Ltd view
JYSZ2100520 阿达木单抗注射液 adalimumab Injection Biological Products License Renew 2021-06-10 Abbvie Ltd;AbbVie Pharmaceutical Trading (Shanghai) Co Ltd view
JYSB2200014 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2022-01-27 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
CYSB2300050 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2023-02-23 Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd view
CYSB2200046 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2022-02-15 Innovent Biologics (Suzhou) Co Ltd view
CYSB2400051 阿达木单抗注射液 adalimumab Injection Biological Products(原2) Supplementary Application 2024-02-29 Shanghai Henlius Biopharmaceutical Co Ltd view
JYSB2101156 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2021-11-03 Vetter Pharma-Fertigung Gmbh & Co KG;Abbvie Deutschland Gmbh & Co KG view
CYSB2400326 阿达木单抗注射液 adalimumab Injection Biological Products Supplementary Application 2024-12-14 Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd view
CYSB2200205 阿达木单抗注射液 adalimumab Injection Biological Products(3.3) Supplementary Application 2022-08-19 Shanghai Junshi Biosciences Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd view